Turbine
AI-powered drug discovery company using simulation biology to predict how cancer cells respond to treatments, enabling identification of novel drug combinations and resistance mechanisms.
Website
https://www.turbine.aiLocation
Budapest, Hungary
Founded
2015
Investors
1
Categories
ai, drug-discovery, simulation, oncology, computational-biology
Notes
Turbine is an AI-powered drug discovery company using simulation biology to predict how cancer cells respond to treatments. The company is headquartered in Budapest, Hungary.
Turbine's platform uses AI and computational modeling to simulate cancer cell behavior at the molecular level, enabling:
- Prediction of drug responses
- Identification of novel drug combinations
- Understanding of resistance mechanisms
- Biomarker discovery
- Patient stratification
The company's simulation-based approach allows for rapid hypothesis testing and drug candidate prioritization, potentially accelerating the drug discovery process.
Team
- Szabolcs Nagy, Ph.D. - Founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/szabolcsnagy
Additional Research Findings
- Portfolio company of Polaris Partners
- AI-driven drug discovery platform
- Simulation biology approach
- Oncology focus
- Budapest, Hungary headquarters
- Founded in 2015
- Cancer cell response prediction
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |